{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:40:02Z","timestamp":1750160402336,"version":"3.41.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymgmr.2025.101212","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T01:47:51Z","timestamp":1743904071000},"page":"101212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outcome of creatine supplementation therapy in phosphoglucomutase-1 deficiency associated congenital disorders of glycosylation: Novel insights"],"prefix":"10.1016","volume":"43","author":[{"given":"Anastasia","family":"Ambrose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morganne","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iveta","family":"Sosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Seres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadet","family":"Mercimek-Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1963","series-title":"Skeletal Muscle Glycogenosis: An Investigation of Two Dissimilar Cases1","author":"Thomson","key":"10.1016\/j.ymgmr.2025.101212_bb0005"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108530","article-title":"Coagulation abnormalities and vascular complications are common in PGM1-CDG","volume":"142","author":"Radenkovic","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jimd.12286","article-title":"International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): diagnosis, follow-up, and management","volume":"44","author":"Altassan","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2014.06.002","article-title":"Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG","volume":"112","author":"Morava","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20050857","article-title":"Effects of N-linked glycosylation on the creatine transporter","volume":"393","author":"Straumann","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MOP.0000000000000954","article-title":"Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines","volume":"32","author":"Barcelos","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0045","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1299::AID-MUS24>3.0.CO;2-4","article-title":"Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies","volume":"22","author":"Borchert","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11940-009-0046-0","article-title":"A modern approach to the treatment of mitochondrial disease","volume":"11","author":"Parikh","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0055","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1249\/01.mss.0000177341.89478.06","article-title":"Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options","volume":"37","author":"Tarnopolsky","year":"2005","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0060","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/mus.1055","article-title":"Creatine transporter and mitochondrial creatine kinase protein content in myopathies","volume":"24","author":"Tarnopolsky","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2002-32372","article-title":"Cerebral white matter involvement in children with mitochondrial encephalopathies","volume":"33","author":"Moroni","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jimd.12406","article-title":"A new D-galactose treatment monitoring index for PGM1-CDG","volume":"44","author":"Perales-Clemente","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0080","article-title":"Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series","volume":"4","author":"Radenkovic","year":"2023","journal-title":"Ther. Adv. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108509","article-title":"Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort","volume":"142","author":"Lam","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0090","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-011-9325-5","article-title":"Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression","volume":"34","author":"Achouitar","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.28313","article-title":"Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations","volume":"36","author":"Perez-Lloret","year":"2021","journal-title":"Mov. Disord."},{"year":"2025","series-title":"Six-Minute Walk Test","author":"Matos Casano","key":"10.1016\/j.ymgmr.2025.101212_bb0100"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/ijd.15341","article-title":"Measuring fatigue: a meta-review","volume":"60","author":"Machado","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1109\/MCSE.2016.93","article-title":"MRICloud: delivering high-throughput MRI neuroinformatics as cloud-based software as a service","volume":"18","author":"Mori","year":"2016","journal-title":"Comput. Sci. Eng."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0120","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mrm.29370","article-title":"MRSCloud\u00a0: a cloud-based MRS tool for basis set simulation","volume":"88","author":"Hui","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1-CDG","volume":"19","author":"Wong","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0130","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2022.10064","article-title":"Involvement of muscle satellite cell dysfunction in neuromuscular disorders: expanding the portfolio of satellite cell-opathies","volume":"32","author":"Ganassi","year":"2022","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0135","article-title":"Update review about metabolic myopathies","volume":"10","author":"Finsterer","year":"2020","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0140","doi-asserted-by":"crossref","first-page":"E1235","DOI":"10.1210\/jc.2013-1651","article-title":"Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency","volume":"98","author":"Preisler","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2017.08.007","article-title":"Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency","volume":"122","author":"Preisler","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/WNL.38.4.602","article-title":"Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels","volume":"38","author":"Sugie","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0155","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2016.04.021","article-title":"Defining the phenotype and assessing severity in phosphoglucomutase-1 deficiency","volume":"175","author":"Wong","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17843286.2016.1142043","article-title":"PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure","volume":"71","author":"Zeevaert","year":"2016","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0170","first-page":"137","article-title":"Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient","volume":"35","author":"Ondruskova","year":"2014","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0175","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nmd.2017.01.014","article-title":"PGM1 deficiency: substrate use during exercise and effect of treatment with galactose","volume":"27","author":"Voermans","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1017\/S1047951103000702","article-title":"Cardiomyopathy in congenital disorders of glycosylation","volume":"13","author":"Gehrmann","year":"2003","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0185","series-title":"JIMD Rep","first-page":"77","article-title":"News on clinical details and treatment in PGM1-CDG","author":"Schrapers","year":"2016"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0190","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","article-title":"Muscle glycogenosis due to phosphoglucomutase 1 deficiency","volume":"361","author":"Stojkovic","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nmd.2019.01.001","article-title":"Congenital disorder of glycosylation type 1T with a novel truncated homozygous mutation in PGM1 gene and literature review","volume":"29","author":"Tian","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2010.06.021","article-title":"l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation","volume":"101","author":"Edvardson","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.nmd.2013.04.011","article-title":"Creatine deficiency syndrome. A treatable myopathy due to arginine-glycine amidinotransferase (AGAT) deficiency","volume":"23","author":"Nouioua","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fphys.2018.00773","article-title":"A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism","volume":"9","author":"Stockebrand","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/pn-2023-003954","article-title":"Arginine:glycine amidinotransferase (AGAT) deficiency: an easy-to-miss treatable adult-onset myopathy","volume":"24","author":"Finezilber","year":"2024","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10545-006-0123-4","article-title":"X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype","volume":"29","author":"Anselm","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajmg.a.30473","article-title":"Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families","volume":"132A","author":"Mancini","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10545-008-1063-y","article-title":"The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation","volume":"33","author":"Puusepp","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0235","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","article-title":"X-linked creatine transporter deficiency: clinical aspects and pathophysiology","volume":"37","author":"van de Kamp","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cge.12355","article-title":"Genotype\u2013phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1","volume":"87","author":"van de Kamp","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgmr.2025.101212_bb0245","series-title":"GeneReviews\u00ae","article-title":"Creatine deficiency disorders","author":"Mercimek-Andrews","year":"2009"},{"key":"10.1016\/j.ymgmr.2025.101212_bb0250","series-title":"GeneReviews\u00ae","article-title":"Classic galactosemia and clinical variant galactosemia","author":"Berry","year":"2000"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:24:51Z","timestamp":1750159491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S2214426925000278"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101212","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of creatine supplementation therapy in phosphoglucomutase-1 deficiency associated congenital disorders of glycosylation: Novel insights","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101212"}}